An experimental GLP-1 pushes the limits of weight loss. There are risks. - The Washington Post

By Christopher Rowland | Published: May 29, 2026

Eli Lilly this month unveiled startling new data that showed an experimental weight-loss drug caused people with obesity to shed, on average, 28 percent of their body weight a substantial step up in … [+49 chars]